Chemotherapy: 1,904 Real Stories

1,904 stories match chemotherapy. 1,436 of them mention surgery.

Cancer Stories

A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV ER/PR-positive mucinous breast cancer: long-term no evidence of disease after surgery, AFTV, radiation, CEF, and endocrine therapy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER-positive; PR-positive; delayed-type hypersensitivity to AFTV became pseudo-positive after vaccination and remained pseudo-positive 5.4 years later

Metastatic Site: Th7 vertebra

More than 6 years after primary surgery, she remained well with no evidence of vertebral metastasis activity, new metastasis, or local recurrence.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Ovarian CancerOvarian Cancer

Recurrent Ovarian Cancer With Tumor Lysis Syndrome After Chemotherapy

Patient Info: Anonymized, female, 60s | Stage IV

Metastatic Site: lungs

After 9 years of stable disease, the ovarian cancer progressed extensively and the first cycle of renewed chemotherapy was complicated by severe tumor lysis syndrome and multiorgan illness.

PubMed Central
OutcomeSetback / Progression
Robin, who was diagnosed with Breast CancerBreast Cancer

Triple-Negative Breast Cancer: Robin's Survivor Story

Patient Info: Robin Roberts, Female

Biomarkers: Triple-negative breast cancer

As of February 2013, Robin was being honored as a triple-negative breast cancer survivor after going public, receiving chemotherapy, and returning to public life; no formal NED status was stated.

YouTube — TNBCFoundation
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

ER-positive breast cancer recurrence with renal metastasis inside angiomyolipoma

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: ER-positive; mammaglobulin-positive; e-cadherin-positive; GCDFP-15-positive; melan A positive in angiomyolipoma component

Metastatic Site: right subpectoral lymph node, left kidney

At 7 months after nephrectomy, she continued anti-estrogen hormonal therapy with no demonstrable progression of disease; surgical excision of the subpectoral lymph node was offered but declined.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

BRCA1-associated right invasive ductal carcinoma followed by left acinic cell carcinoma of the breast

Patient Info: Anonymized, Female, 40s

Biomarkers: Constitutional BRCA1 mutation. Right breast cancer was ER/PR positive, HER2 negative; later left tumor was triple-negative with TP53 change.

After treatment for right invasive ductal carcinoma and later contralateral acinic cell carcinoma, she was alive and well 19 months after the acinic cell carcinoma surgery, with no evidence of disease while continuing hormonal therapy.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Lung Squamous Cell CarcinomaLung Cancer

Stage IIIA squamous lung cancer with later kidney and paraaortic lymph node metastases

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: Squamous lung cancer markers supported the diagnosis; TTF-1, CK7 and CK20 were not seen; Ki-67 >10%.

Metastatic Site: left renal parenchyma, paraaortic lymph nodes

After surgery, 4 cycles of cisplatin plus vinblastine, and mediastinal radiotherapy, she had a 10-month disease-free interval before biopsy-confirmed metastatic squamous lung carcinoma appeared in the left kidney with paraaortic lymph node enlargement.

PubMed Central
OutcomeSetback / Progression
A patient, who was diagnosed with Stage IV Ovarian AdenocarcinomaOvarian Cancer

Ovarian Cancer That Spread to the Cerebellum 10 Years Later

Patient Info: Anonymized, female, Under 40 | Stage IV

Metastatic Site: right cerebellum

After removal of the cerebellar metastasis, her headache and vertigo improved and she subsequently received whole-brain radiation.

PubMed Central
OutcomeNot reported
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Sigmoid colon cancer: complete response after repeated metastatic recurrences and multimodal therapy

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: KRAS/NRAS/BRAF status not reported; CEA elevation used for recurrence monitoring

Metastatic Site: left lung, mediastinal lymph nodes, left adrenal…

By 2011, all metastatic lesions had achieved complete response; nearly 1 year after the last adrenal irradiation, no recurrence had been detected.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

ER/PR-positive breast cancer with bilateral ovarian metastases controlled after oophorectomy and aromatase inhibitor

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-negative; CK7-positive; gross cystic disease fluid protein-15-positive; CK20-negative

Metastatic Site: bilateral ovaries

After bilateral oophorectomies and aromatase inhibitor therapy, pleural effusion resolved, CEA and CA 15-3 decreased below the normal upper limit, and she remained well with no further recurrence for 40 months.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage I Ovarian CancerOvarian Cancer

Mucinous Ovarian Cancer Treated During Pregnancy

Patient Info: Anonymized, female, Under 40 | Stage I

The woman and her baby were followed for more than 5 years, and the mother had no evidence of ovarian cancer recurrence during that period.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

EGFR L858R-mutant Stage IV lung adenocarcinoma managed after gefitinib-induced lung injury

Patient Info: Anonymized, Male, 40s | Stage IV

Biomarkers: EGFR L858R mutation

Metastatic Site: liver, bone, hilar lymph nodes, mediastinal lymph…

Gefitinib produced early tumor shrinkage but was stopped for interstitial lung disease; subsequent carboplatin, pemetrexed, and bevacizumab produced a good response, while variceal bleeding was controlled with endoscopic treatment.

PubMed Central
OutcomeResponding Well
A patient, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III sigmoid colon invasive micropapillary carcinoma treated with sigmoidectomy and modified FOLFOX6

Patient Info: Anonymized, Male, 70+ | Stage III

Biomarkers: CEA normal; CA 19-9 normal; MUC1 inside-out staining pattern in micropapillary component

After diagnostic endoscopic resection, sigmoidectomy with regional lymph node resection, and 6 cycles of modified FOLFOX6, he was in good condition with no evidence of recurrence 12 months after surgery.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Papillary Thyroid-Type Cancer Arising in Struma Ovarii

Patient Info: Anonymized, female, 40s

Six months after surgery, imaging showed no recurrence or metastasis and thyroglobulin was undetectable, supporting remission.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Lung CancerLung Cancer

Stage IV EBV-positive lymphoepithelioma-like lung cancer with brain metastasis

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: EBV-positive by in-situ hybridization

Metastatic Site: brain, retroperitoneal/posterior mediastinal soft…

Remained well and disease-free 6 months after resection of the retroperitoneal/posterior mediastinal metastasis and 8 years after initial presentation.

PubMed Central
OutcomeCancer-Free / NED